We're trimming a big winner and buying the dip in a stock that shouldn't be down

We are making two trades Wednesday: Selling 15 shares of Goldman Sachs at roughly $938 each, which leaves Jim Cramer's Charitable Trust with 170 shares of GS, decreasing its weight in the portfolio to 4.15% from 4.5% Buying 65 shares of Johnson & Johnson at roughly $223, which brings the Trust's JNJ ownership to 290 shares, increasing its weight in the portfolio to 1.7% from 1.3% Goldman Sachs We're locking in big profits on our Goldman Sachs position as shares of the investment banking giant …